Feldstein AE - Search Results

1

Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease.

Feldstein AE, Papouchado BG, Angulo P, Sanderson S, Adams L, Gores GJ. Feldstein AE, et al. Clin Gastroenterol Hepatol. 2005 Apr;3(4):384-9. doi: 10.1016/s1542-3565(04)00616-0. Clin Gastroenterol Hepatol. 2005. PMID: 15822044

2

Primary sclerosing cholangitis in children: a long-term follow-up study.

Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Feldstein AE, et al. Hepatology. 2003 Jul;38(1):210-7. doi: 10.1053/jhep.2003.50289. Hepatology. 2003. PMID: 12830004

3

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.

Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ. Canbay A, et al. J Clin Invest. 2003 Jul;112(2):152-9. doi: 10.1172/JCI17740. J Clin Invest. 2003. PMID: 12865404 Free PMC article.

4

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Feldstein AE, et al. Gastroenterology. 2003 Aug;125(2):437-43. doi: 10.1016/s0016-5085(03)00907-7. Gastroenterology. 2003. PMID: 12891546

5

Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.

Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ. Canbay A, et al. Among authors: feldstein ae. Hepatology. 2003 Nov;38(5):1188-98. doi: 10.1053/jhep.2003.50472. Hepatology. 2003. PMID: 14578857

6

The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.

Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. Canbay A, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):1191-6. doi: 10.1124/jpet.103.060129. Epub 2003 Nov 14. J Pharmacol Exp Ther. 2004. PMID: 14617689

7

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.

Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ. Feldstein AE, et al. J Hepatol. 2003 Dec;39(6):978-83. doi: 10.1016/s0168-8278(03)00460-4. J Hepatol. 2003. PMID: 14642615

8

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.

Adams LA, Feldstein A, Lindor KD, Angulo P. Adams LA, et al. Hepatology. 2004 Apr;39(4):909-14. doi: 10.1002/hep.20140. Hepatology. 2004. PMID: 15057893

9

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.

Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ. Feldstein AE, et al. Hepatology. 2004 Jul;40(1):185-94. doi: 10.1002/hep.20283. Hepatology. 2004. PMID: 15239102

10

Steatohepatitis and apoptosis: therapeutic implications.

Feldstein A, Gores GJ. Feldstein A, et al. Am J Gastroenterol. 2004 Sep;99(9):1718-9. doi: 10.1111/j.1572-0241.2004.40573.x. Am J Gastroenterol. 2004. PMID: 15330908 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters